Author: Yalcin Kehribar, Demet; Cihangiroglu, Mustafa; Sehmen, Emine; Avci, Bahattin; Capraz, Aylin; Yildirim Bilgin, Ayse; Gunaydin, Caner; Ozgen, Metin
Title: The receptor for advanced glycation end product (RAGE) pathway in COVID-19 Cord-id: kjqfmqox Document date: 2021_1_13
ID: kjqfmqox
Snippet: INTRODUCTION: Coronavirus disease-2019 (COVID-19) with lung involvement frequently causes morbidity and mortality. Advanced age appears to be the most important risk factor. The receptor for advanced glycation end-product (RAGE) pathway is considered to play important roles in the physiological aging and pathogenesis of lung diseases. This study aimed to investigate the possible relationship between COVID-19 and RAGE pathway. MATERIALS AND METHODS: This study included 23 asymptomatic patients an
Document: INTRODUCTION: Coronavirus disease-2019 (COVID-19) with lung involvement frequently causes morbidity and mortality. Advanced age appears to be the most important risk factor. The receptor for advanced glycation end-product (RAGE) pathway is considered to play important roles in the physiological aging and pathogenesis of lung diseases. This study aimed to investigate the possible relationship between COVID-19 and RAGE pathway. MATERIALS AND METHODS: This study included 23 asymptomatic patients and 35 patients with lung involvement who were diagnosed with COVID-19 as well as 22 healthy volunteers. Lung involvement was determined using computed tomography. Serum soluble-RAGE (sRAGE) levels were determined using enzyme-linked immunosorbent assay. RESULTS: The sRAGE levels were significantly higher in the asymptomatic group than in the control group. Age, fibrinogen, C-reactive protein, and ferritin levels were higher and the sRAGE level was lower in the patients with lung involvement than in the asymptomatic patients. CONCLUSIONS: In this study, patients with high sRAGE levels were younger and had asymptomatic COVID-19. Patients with low sRAGE levels were elderly patients with lung involvement, which indicates that the RAGE pathway plays an important role in the aggravation of COVID-19.
Search related documents:
Co phrase search for related documents- absence death and lung disease: 1
- ace inhibitor and acute ards respiratory distress syndrome: 1, 2, 3, 4
- ace inhibitor and acute phase: 1
- ace inhibitor and lung disease: 1
- ace receptor and acute ards respiratory distress syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24
- ace receptor and acute phase: 1, 2, 3
- ace receptor and lung disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
- ace receptor and lung disease pathogenesis: 1
- ace receptor and lung involvement: 1
- acute ards respiratory distress syndrome and lung disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- acute ards respiratory distress syndrome and lung disease pathogenesis: 1, 2, 3, 4, 5
- acute ards respiratory distress syndrome and lung involvement: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- acute ards respiratory distress syndrome patient and lung disease: 1
- acute phase and lung disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- acute phase and lung disease pathogenesis: 1
- acute phase and lung involvement: 1, 2, 3, 4, 5, 6, 7, 8, 9
- acute phase level and lung disease: 1, 2
- acute phase level and lung disease pathogenesis: 1
Co phrase search for related documents, hyperlinks ordered by date